Literature DB >> 1860692

Biliary excretion of bile acid conjugates in a hyperbilirubinemic mutant Sprague-Dawley rat.

H Takikawa1, N Sano, T Narita, Y Uchida, M Yamanaka, T Horie, T Mikami, O Tagaya.   

Abstract

The hepatic transport of bile acid conjugates was studied in the Eisai hyperbilirubinuria rat, a Sprague-Dawley mutant rat with conjugated hyperbilirubinemia. Serum bile acid levels were increased, bile acid-independent bile flow was decreased and biliary glutathione concentrations were markedly decreased in the Eisai hyperbilirubinuria rat. Biliary excretion of sulfobromophthalein was markedly impaired and almost no glutathione conjugate was excreted in the bile of the Eisai hyperbilirubinuria rat. Biliary excretion of lithocholate-3-O-glucuronide and lithocholate-3-sulfate in the Eisai hyperbilirubinuria rat was markedly delayed, whereas that of lithocholate was only slightly delayed. After [14C]chenodeoxycholate infusion (1 mumol/min/100 gm for 60 min), the increases in bile flow and biliary excretion of isotope in the Eisai hyperbilirubinuria rat were not so prominent as those observed in control rats, and the glucuronide of chenodeoxycholate, which constituted about 15% of biliary chenodeoxycholate in control rats, was not observed in the Eisai hyperbilirubinuria rat. Initial uptake of lithocholate and its glucuronide and sulfate by isolated hepatocytes was not impaired in the Eisai hyperbilirubinuria rat; the profiles of cytosolic bile acid binding proteins in Eisai hyperbilirubinuria rat liver were identical to those in control liver. These data indicate that the Eisai hyperbilirubinuria rat has excretory impairment of organic anions, bile acid glucuronide and sulfate and that it has characteristics very similar to those of the hyperbilirubinemic mutant Wistar rats TR- and GY.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1860692

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  30 in total

Review 1.  MRP subfamily transporters and resistance to anticancer agents.

Authors:  G D Kruh; H Zeng; P A Rea; G Liu; Z S Chen; K Lee; M G Belinsky
Journal:  J Bioenerg Biomembr       Date:  2001-12       Impact factor: 2.945

2.  Effects of ursodeoxycholate and its conjugates on biliary glutathione excretion in rats.

Authors:  H Takikawa; N Sano; M Yamanaka
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

3.  An in vivo role of Mrp2 in the rat hepatocytes by immunocytochemistry for amoxicillin using the transporter-deficient EHBR.

Authors:  Kunio Fujiwara; Masashi Shin; Yohei Yoshizaki; Tsubasa Miyazaki; Tetsuya Saita
Journal:  J Mol Histol       Date:  2012-03-25       Impact factor: 2.611

4.  Effects of organic anions and bile acid conjugates on biliary excretion of pravastatin in the rat.

Authors:  S Fukumura; H Takikawa; M Yamanaka
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

5.  Regulation of multidrug resistance-associated protein 2 by calcium signaling in mouse liver.

Authors:  Laura N Cruz; Mateus T Guerra; Emma Kruglov; Albert Mennone; Celia R S Garcia; Ju Chen; Michael H Nathanson
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

6.  Dexamethasone- and osmolarity-dependent expression of the multidrug-resistance protein 2 in cultured rat hepatocytes.

Authors:  R Kubitz; U Warskulat; M Schmitt; D Häussinger
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

7.  Mechanisms of biliary excretion of lithocholate-3-sulfate in Eisai hyperbilirubinemic rats (EHBR).

Authors:  H Takikawa; K Nishikawa; N Sano; M Yamanaka; T Horie
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

8.  Relationship between biliary excretion of bilirubin and glutathione disulfide.

Authors:  Y Kuronuma; H Yoshida; M Iijima; T Harada
Journal:  Gastroenterol Jpn       Date:  1993-04

9.  Biliary and renal excretions of cefpiramide in Eisai hyperbilirubinemic rats.

Authors:  I Muraoka; T Hasegawa; M Nadai; L Wang; S Haghgoo; O Tagaya; T Nabeshima
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

10.  Mechanistic Modeling of the Hepatic Disposition of Estradiol-17β-Glucuronide in Sandwich-Cultured Human Hepatocytes.

Authors:  Katsuaki Ito; Noora Sjöstedt; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2019-11-19       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.